SCHEMBL7103042

SCHEMBL7103042

N#CNC(=Nc1ccncc1)NCCCCCCOC(=O)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
IKBKB O14920 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.39
PRSS1 P07477 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 1/20 0.36
HRH4 Q9H3N8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL504314 0.87 HDAC3 (0.46) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7696942 0.87 NAMPT (0.48) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504928 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504484 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504473 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504474 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504485 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504929 0.85 CYP2C9 (0.40) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
Chs-828 SCHEMBL504151 0.85 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL505054 0.85 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984938-B1 CYANOGUANIDINES AS CELL PROLIFERATION INHIBITORS LEO PHARMA AS WITH SECONDARY N (DK) 2003-09-10 EP claimed
US-6346541-B1 ANTITUMOR AND ANTICARCINOGENIC AGENTS FOR BREAST, LUNG, AND SKIN CANCER LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-12 US claimed
EP-0984938-B1 CYANOGUANIDINES AS CELL PROLIFERATION INHIBITORS LEO PHARMA AS WITH SECONDARY N (DK) 2003-09-10 EP disclosed
US-6346541-B1 ANTITUMOR AND ANTICARCINOGENIC AGENTS FOR BREAST, LUNG, AND SKIN CANCER LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-12 US disclosed